宫颈癌

工具分子

造模剂

7,12-Dimethylbenz[a]anthracene

N-Nitroso-N-methylurea

缺氧标志物

Pimonidazole

获批药物

NCCN指南推荐 ^[1]

一线全身性治疗

Pembrolizumab

Cisplatin

Paclitaxel

Bevacizumab

Topotecan

二线全身性治疗

Pembrolizumab

Tisotumab vedotin

Cemiplimab

Paclitaxel

Nab-Paclitaxel

Docetaxel

5-FU

Gemcitabine

Pemetrexed

Topotecan

Vinorelbine ditartrate

Irinotecan

化疗方案

CARBOPLATIN-TAXOL

Carboplatin

Paclitaxel

GEMCITABINE-CISPLATIN

Gemcitabine HCl

Cisplatin

抗病毒感染

抗HPV感染

Isoprinosine

N-p-Tosyl-L-phenylalanine chloromethyl ketone

Vorinostat

A2ti-1

A2ti-2

抗HIV感染

Doxorubicin HCl

Plerixafor

Triciribine

Birinapant

Cenicriviroc

免疫检查点抑制剂

PD-1

Pembrolizumab

Dostarlimab

Cemiplimab

Camrelizumab

Sintilimab

Nivolumab

Serplulimab

Balstilimab

PD-L1

Atezolizumab

Durvalumab

Avelumab

Adebrelimab

Sugemalimab

CTLA-4

Nurulimab

Zalifrelimab

Quavonlimab

Ipilimumab

Tremelimumab

TIGHT

Tiragolumab

Vibostolimab

Domvanalimab

Ociperlimab

抗血管生成 ^[2]

VEGF

Bevacizumab

Pazopanib

Lapatinib

Brivanib

TKIs

Sunitinib

Imatinib

Angiotensin

Angiotensin II human Acetate

Angiotensin

Azilsartan

Olmesartan

靶向疗法 (A) ^[3]

CD44

Bivatuzumab

Angstrom6

ALDH

Disulfiram

Daidzin

NCT-501

Alda 1

CM10

ABCG2

Ko143

RG14620

YHO-13177

KS176

5,7-Dimethoxyflavone

NANOG

Amcasertib

BMI1

PTC-209

PTC-209 HBr

PRT4165

Unesbulin

PTC-028

靶向疗法 (B) ^[3]

LGR5

Petosemtamab

OCT3/4

O4I2

O4I1

α-SMA

CCG-222740

Apamin

Vimentin

Withaferin A

KLF4

APTO-253

β-catenin

IWP-2

Laduviglusib

Capmatinib

c-Myc

10058-F4

dBET6

10074-G5

干细胞标志物 ^[3]

NANOG

Amcasertib

KLF4

APTO-253

CD133

Amcasertib

Cd44

Bivatuzumab

Angstrom6

ALDH1

Disulfiram

NCT-501

CM10

ABCG2

Ko143

RG14620

YHO-13177

KS176

5,7-Dimethoxyflavone

BMI1

PTC-209

PTC-209 HBr

PRT4165

Unesbulin

PTC-028

LGR5

Petosemtamab

上皮-间质转化 ^[3]

BMI1

PTC-209

PTC-209 HBr

PRT4165

Unesbulin

PTC-028

Vimentin

Withaferin A

相关化合物库